<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00395135</url>
  </required_header>
  <id_info>
    <org_study_id>APD356-009</org_study_id>
    <nct_id>NCT00395135</nct_id>
  </id_info>
  <brief_title>BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management</brief_title>
  <official_title>BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management; A 104-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety and Efficacy of Lorcaserin Hydrochloride in Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arena Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arena Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the weight loss effect of lorcaserin at the end of the
      first year of treatment (Week 52) and to assess the ability of lorcaserin to maintain weight
      loss at the end of the second year of treatment (Week 104)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">February 2009</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Year 1: Co-Primary Endpoint- Proportion (%) of Patients Achieving &gt; or = 5% Weight Loss From Baseline to Week 52</measure>
    <time_frame>52 weeks</time_frame>
    <description>The proportion of patients with a reduction from baseline body weight of 5% or more at the end of year 1.
Other co-primary endpoints are change from baseline in body weight (kg) at year 1 and the proportion of patients achieving ≥ 10% reduction in body weight at year 1.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Year 2: Proportion (%) of Patients Maintaining &gt; or = 5% Weight Loss at Week 104</measure>
    <time_frame>104 weeks</time_frame>
    <description>The proportion of patients with a reduction from baseline body weight of 5% or more at the end of year 1 and who maintained this reduction during year 2.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Year 1: Percent Change in Body Weight From Baseline to Week 52</measure>
    <time_frame>52 weeks</time_frame>
    <description>Year 1: The % change in body weight (kg) from baseline to week 52.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Year 2: Percent Change in Body Weight From Week 52 to Week 104</measure>
    <time_frame>52 weeks</time_frame>
    <description>Year 2: The % change in body weight (kg) from week 52 to week 104.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3182</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Lorcaserin 10 mg BID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lorcaserin 10 mg tablet each morning and evening</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Matching Placebo BID</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo tablet each morning and evening</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lorcaserin 10 mg BID</intervention_name>
    <description>Lorcaserin 10 mg tablet each morning and evening for a duration of 52 or 104 weeks.</description>
    <arm_group_label>Lorcaserin 10 mg BID</arm_group_label>
    <other_name>APD356</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Matching Placebo BID</intervention_name>
    <description>Matching placebo tablet each morning and evening for a duration of 52 or 104 weeks.</description>
    <arm_group_label>Matching Placebo BID</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obese adults with a BMI 30 to 45 kg/m2 or overweight adults with a BMI 27 to 29.9
             kg/m2 and at least one obesity-related comorbidity (hypertension, dyslipidemia,
             cardiovascular disease, glucose intolerance, sleep apnea)

          -  Ability to complete a 2 year study

        Exclusion Criteria:

          -  Diabetes

          -  Pregnancy

          -  History of heart valve disease

          -  Serious or unstable current or past medical conditions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Shanahan, MD</last_name>
    <role>Study Director</role>
    <affiliation>Arena Pharmaceuticals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Smith, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Neil Weissman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MedStar Health Research Institute, Georgetown University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arena Pharmaceuticals, Inc.</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.arenapharm.com</url>
    <description>Arena Pharmaceuticals, Inc. Home Page</description>
  </link>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2006</study_first_submitted>
  <study_first_submitted_qc>October 31, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2006</study_first_posted>
  <results_first_submitted>January 4, 2013</results_first_submitted>
  <results_first_submitted_qc>January 4, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 7, 2013</results_first_posted>
  <disposition_first_submitted>July 26, 2012</disposition_first_submitted>
  <disposition_first_submitted_qc>August 6, 2012</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">August 14, 2012</disposition_first_posted>
  <last_update_submitted>January 4, 2013</last_update_submitted>
  <last_update_submitted_qc>January 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Weight loss</keyword>
  <keyword>lorcaserin</keyword>
  <keyword>APD356</keyword>
  <keyword>BLOOM</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Dyslipidemia</keyword>
  <keyword>Sleep apnea</keyword>
  <keyword>glucose tolerance</keyword>
  <keyword>cardiovascular disease</keyword>
  <keyword>Arena</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Year 1 - Lorcaserin 10 mg BID</title>
          <description>lorcaserin 10 mg BID tablets</description>
        </group>
        <group group_id="P2">
          <title>Year 1 - Matching Placebo BID</title>
          <description>matching placebo tablets</description>
        </group>
        <group group_id="P3">
          <title>Year 2 - Lorc 10 mg BID (Yr 1) / Lorc 10 mg BID (Yr 2)</title>
          <description>Patients were randomized to lorcaserin in Year 1, completed year 1 study and randomized to lorcaserin in Year 2.</description>
        </group>
        <group group_id="P4">
          <title>Year 2 - Lorc 10 mg BID (Yr 1) / Placebo (Yr 2)</title>
          <description>Patients were randomized to lorcaserin in Year 1, completed year 1 study and randomized to placebo in Year 2.</description>
        </group>
        <group group_id="P5">
          <title>Year 2 - Placebo (Yr 1) / Placebo (Yr 2)</title>
          <description>Patients randomized to placebo in Year 1, completed year 1 and randomized to receive placebo in Year 2.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Year 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1595"/>
                <participants group_id="P2" count="1587"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="883"/>
                <participants group_id="P2" count="716"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="712"/>
                <participants group_id="P2" count="871"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Year 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="573"/>
                <participants group_id="P4" count="283"/>
                <participants group_id="P5" count="697"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="426"/>
                <participants group_id="P4" count="195"/>
                <participants group_id="P5" count="507"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="147"/>
                <participants group_id="P4" count="88"/>
                <participants group_id="P5" count="190"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Year 1 - Lorcaserin 10 mg BID</title>
          <description>lorcaserin 10 mg BID tablets</description>
        </group>
        <group group_id="B2">
          <title>Year 1 - Matching Placebo BID</title>
          <description>matching placebo tablets</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1593"/>
            <count group_id="B2" value="1584"/>
            <count group_id="B3" value="3177"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.8" spread="11.32"/>
                    <measurement group_id="B2" value="44.4" spread="11.11"/>
                    <measurement group_id="B3" value="44.1" spread="11.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1321"/>
                    <measurement group_id="B2" value="1331"/>
                    <measurement group_id="B3" value="2652"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="272"/>
                    <measurement group_id="B2" value="253"/>
                    <measurement group_id="B3" value="525"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Year 1: Co-Primary Endpoint- Proportion (%) of Patients Achieving &gt; or = 5% Weight Loss From Baseline to Week 52</title>
        <description>The proportion of patients with a reduction from baseline body weight of 5% or more at the end of year 1.
Other co-primary endpoints are change from baseline in body weight (kg) at year 1 and the proportion of patients achieving ≥ 10% reduction in body weight at year 1.</description>
        <time_frame>52 weeks</time_frame>
        <population>MITT with LOCF</population>
        <group_list>
          <group group_id="O1">
            <title>Lorcaserin 10 mg BID</title>
            <description>lorcaserin 10 mg BID tablets</description>
          </group>
          <group group_id="O2">
            <title>Matching Placebo BID</title>
            <description>matching placebo tablets</description>
          </group>
        </group_list>
        <measure>
          <title>Year 1: Co-Primary Endpoint- Proportion (%) of Patients Achieving &gt; or = 5% Weight Loss From Baseline to Week 52</title>
          <description>The proportion of patients with a reduction from baseline body weight of 5% or more at the end of year 1.
Other co-primary endpoints are change from baseline in body weight (kg) at year 1 and the proportion of patients achieving ≥ 10% reduction in body weight at year 1.</description>
          <population>MITT with LOCF</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1538"/>
                <count group_id="O2" value="1499"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.5"/>
                    <measurement group_id="O2" value="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>ANCOVA</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>3.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>3.0</ci_lower_limit>
            <ci_upper_limit>4.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Year 2: Proportion (%) of Patients Maintaining &gt; or = 5% Weight Loss at Week 104</title>
        <description>The proportion of patients with a reduction from baseline body weight of 5% or more at the end of year 1 and who maintained this reduction during year 2.</description>
        <time_frame>104 weeks</time_frame>
        <population>MITT with LOCF</population>
        <group_list>
          <group group_id="O1">
            <title>Lorcaserin 10 mg BID (Yr 1) / Lorcaserin 10 mg BID (Yr 2)</title>
            <description>Patients were randomized to lorcaserin in Year 1, completed year 1 study with a &quot;Responder&quot; status and randomized to lorcaserin in Year 2.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg BID (Yr 1) / Matching Placebo (Yr 2)</title>
            <description>Patients were randomized to lorcaserin in Year 1, completed year 1 with a &quot;Responder&quot; status and randomized to placebo in Year 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Year 2: Proportion (%) of Patients Maintaining &gt; or = 5% Weight Loss at Week 104</title>
          <description>The proportion of patients with a reduction from baseline body weight of 5% or more at the end of year 1 and who maintained this reduction during year 2.</description>
          <population>MITT with LOCF</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="380"/>
                <count group_id="O2" value="175"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.9"/>
                    <measurement group_id="O2" value="50.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Year 1: Percent Change in Body Weight From Baseline to Week 52</title>
        <description>Year 1: The % change in body weight (kg) from baseline to week 52.</description>
        <time_frame>52 weeks</time_frame>
        <population>MITT with LOCF</population>
        <group_list>
          <group group_id="O1">
            <title>Lorcaserin 10 mg BID</title>
            <description>lorcaserin 10 mg BID tablets</description>
          </group>
          <group group_id="O2">
            <title>Matching Placebo BID</title>
            <description>matching placebo tablets</description>
          </group>
        </group_list>
        <measure>
          <title>Year 1: Percent Change in Body Weight From Baseline to Week 52</title>
          <description>Year 1: The % change in body weight (kg) from baseline to week 52.</description>
          <population>MITT with LOCF</population>
          <units>% change from baseline: body wt (kg)</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1538"/>
                <count group_id="O2" value="1499"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.87" spread="0.18"/>
                    <measurement group_id="O2" value="-2.20" spread="0.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>ANCOVA</method>
            <param_type>Difference in proportion (%)</param_type>
            <param_value>-3.67</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.09</ci_lower_limit>
            <ci_upper_limit>-3.25</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Year 2: Percent Change in Body Weight From Week 52 to Week 104</title>
        <description>Year 2: The % change in body weight (kg) from week 52 to week 104.</description>
        <time_frame>52 weeks</time_frame>
        <population>MITT with LOCF</population>
        <group_list>
          <group group_id="O1">
            <title>Lorcaserin 10 mg BID (Yr 1) / Lorcaserin 10 mg BID (Yr 2)</title>
            <description>Patients were randomized to lorcaserin in Year 1, completed year 1 study and randomized to lorcaserin in Year 2.</description>
          </group>
          <group group_id="O2">
            <title>Lorcaserin 10 mg BID (Yr 1) / Matching Placebo (Yr 2)</title>
            <description>Patients were randomized to lorcaserin in Year 1, completed year 1 study and randomized to placebo in Year 2.</description>
          </group>
          <group group_id="O3">
            <title>Placebo (Yr 1) / Placebo (Yr 2)</title>
            <description>Patients were randomized to placebo in Year 1 and randomized to placebo in Year 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Year 2: Percent Change in Body Weight From Week 52 to Week 104</title>
          <description>Year 2: The % change in body weight (kg) from week 52 to week 104.</description>
          <population>MITT with LOCF</population>
          <units>% change from baseline: body wt (kg)</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="553"/>
                <count group_id="O2" value="267"/>
                <count group_id="O3" value="665"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.79" spread="0.23"/>
                    <measurement group_id="O2" value="5.38" spread="0.31"/>
                    <measurement group_id="O3" value="1.15" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>ANCOVA</method>
            <param_type>Difference in proportion (%)</param_type>
            <param_value>-2.58</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.29</ci_lower_limit>
            <ci_upper_limit>-1.88</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>ANCOVA</method>
            <param_type>Difference in proportion (%)</param_type>
            <param_value>1.64</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.10</ci_lower_limit>
            <ci_upper_limit>2.19</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected for a period of up to 2 years. The data is separated by group and by year and is inclusive for each year.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Year 1 - Lorcaserin 10 mg BID</title>
          <description>lorcaserin 10 mg BID tablets</description>
        </group>
        <group group_id="E2">
          <title>Year 1 - Matching Placebo BID</title>
          <description>matching placebo tablets</description>
        </group>
        <group group_id="E3">
          <title>Year 2 - Lorc 10 mg BID (Yr 1) / Lorc 10 mg BID (Yr 2)</title>
          <description>lorcaserin 10 mg BID tablets</description>
        </group>
        <group group_id="E4">
          <title>Year 2 - Lorc 10 mg BID (Yr 1) / Matching Placebo (Yr 2)</title>
          <description>lorcaserin 10 mg BID tablets, matching placebo tablets</description>
        </group>
        <group group_id="E5">
          <title>Year 2 - Placebo (Yr 1) / Placebo (Yr 2)</title>
          <description>matching placebo tablets</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 9.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="1593"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="1584"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="573"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="283"/>
                <counts group_id="E5" subjects_affected="24" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Multiple congenital abnormalities</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Retinal exudates</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Enterocele</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Rectal prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Biliary dyskinesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Epiglottitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Giardiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Gun shot wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Meniscus lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Traumatic brain injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Loose body in joint</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1584"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="573"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Tendon disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Teratoma benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dysphasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Nervous system disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Radiculitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Radiculopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Syncope vasovagal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast hyperplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Menometrorrhagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Uterine haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Uterine malposition</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1593"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="283"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1593"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1584"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="573"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="283"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 9.1</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1324" subjects_at_risk="1593"/>
                <counts group_id="E2" subjects_affected="1203" subjects_at_risk="1584"/>
                <counts group_id="E3" subjects_affected="450" subjects_at_risk="573"/>
                <counts group_id="E4" subjects_affected="210" subjects_at_risk="283"/>
                <counts group_id="E5" subjects_affected="515" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="116" subjects_affected="106" subjects_at_risk="1593"/>
                <counts group_id="E2" events="72" subjects_affected="64" subjects_at_risk="1584"/>
                <counts group_id="E3" events="16" subjects_affected="14" subjects_at_risk="573"/>
                <counts group_id="E4" events="9" subjects_affected="8" subjects_at_risk="283"/>
                <counts group_id="E5" events="11" subjects_affected="11" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="118" subjects_affected="109" subjects_at_risk="1593"/>
                <counts group_id="E2" events="100" subjects_affected="85" subjects_at_risk="1584"/>
                <counts group_id="E3" events="38" subjects_affected="34" subjects_at_risk="573"/>
                <counts group_id="E4" events="10" subjects_affected="9" subjects_at_risk="283"/>
                <counts group_id="E5" events="31" subjects_affected="30" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" events="84" subjects_affected="83" subjects_at_risk="1593"/>
                <counts group_id="E2" events="37" subjects_affected="37" subjects_at_risk="1584"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="573"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="283"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="141" subjects_affected="119" subjects_at_risk="1593"/>
                <counts group_id="E2" events="90" subjects_affected="85" subjects_at_risk="1584"/>
                <counts group_id="E3" events="20" subjects_affected="20" subjects_at_risk="573"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="283"/>
                <counts group_id="E5" events="32" subjects_affected="29" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="108" subjects_affected="95" subjects_at_risk="1593"/>
                <counts group_id="E2" events="51" subjects_affected="48" subjects_at_risk="1584"/>
                <counts group_id="E3" events="15" subjects_affected="15" subjects_at_risk="573"/>
                <counts group_id="E4" events="6" subjects_affected="5" subjects_at_risk="283"/>
                <counts group_id="E5" events="17" subjects_affected="16" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="87" subjects_affected="79" subjects_at_risk="1593"/>
                <counts group_id="E2" events="67" subjects_affected="64" subjects_at_risk="1584"/>
                <counts group_id="E3" events="18" subjects_affected="18" subjects_at_risk="573"/>
                <counts group_id="E4" events="14" subjects_affected="14" subjects_at_risk="283"/>
                <counts group_id="E5" events="25" subjects_affected="21" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="81" subjects_affected="73" subjects_at_risk="1593"/>
                <counts group_id="E2" events="72" subjects_affected="69" subjects_at_risk="1584"/>
                <counts group_id="E3" events="39" subjects_affected="38" subjects_at_risk="573"/>
                <counts group_id="E4" events="15" subjects_affected="14" subjects_at_risk="283"/>
                <counts group_id="E5" events="44" subjects_affected="42" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="249" subjects_affected="213" subjects_at_risk="1593"/>
                <counts group_id="E2" events="223" subjects_affected="190" subjects_at_risk="1584"/>
                <counts group_id="E3" events="114" subjects_affected="94" subjects_at_risk="573"/>
                <counts group_id="E4" events="45" subjects_affected="39" subjects_at_risk="283"/>
                <counts group_id="E5" events="103" subjects_affected="88" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="139" subjects_affected="114" subjects_at_risk="1593"/>
                <counts group_id="E2" events="152" subjects_affected="130" subjects_at_risk="1584"/>
                <counts group_id="E3" events="62" subjects_affected="49" subjects_at_risk="573"/>
                <counts group_id="E4" events="33" subjects_affected="30" subjects_at_risk="283"/>
                <counts group_id="E5" events="59" subjects_affected="48" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="280" subjects_affected="235" subjects_at_risk="1593"/>
                <counts group_id="E2" events="216" subjects_affected="189" subjects_at_risk="1584"/>
                <counts group_id="E3" events="100" subjects_affected="83" subjects_at_risk="573"/>
                <counts group_id="E4" events="41" subjects_affected="31" subjects_at_risk="283"/>
                <counts group_id="E5" events="131" subjects_affected="112" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="132" subjects_affected="106" subjects_at_risk="1593"/>
                <counts group_id="E2" events="112" subjects_affected="96" subjects_at_risk="1584"/>
                <counts group_id="E3" events="48" subjects_affected="41" subjects_at_risk="573"/>
                <counts group_id="E4" events="15" subjects_affected="14" subjects_at_risk="283"/>
                <counts group_id="E5" events="37" subjects_affected="35" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="79" subjects_affected="70" subjects_at_risk="1593"/>
                <counts group_id="E2" events="87" subjects_affected="75" subjects_at_risk="1584"/>
                <counts group_id="E3" events="44" subjects_affected="38" subjects_at_risk="573"/>
                <counts group_id="E4" events="18" subjects_affected="17" subjects_at_risk="283"/>
                <counts group_id="E5" events="51" subjects_affected="43" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="114" subjects_affected="99" subjects_at_risk="1593"/>
                <counts group_id="E2" events="93" subjects_affected="89" subjects_at_risk="1584"/>
                <counts group_id="E3" events="39" subjects_affected="34" subjects_at_risk="573"/>
                <counts group_id="E4" events="19" subjects_affected="16" subjects_at_risk="283"/>
                <counts group_id="E5" events="33" subjects_affected="30" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="149" subjects_affected="130" subjects_at_risk="1593"/>
                <counts group_id="E2" events="69" subjects_affected="60" subjects_at_risk="1584"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="573"/>
                <counts group_id="E4" events="8" subjects_affected="8" subjects_at_risk="283"/>
                <counts group_id="E5" events="17" subjects_affected="17" subjects_at_risk="697"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="388" subjects_affected="287" subjects_at_risk="1593"/>
                <counts group_id="E2" events="211" subjects_affected="175" subjects_at_risk="1584"/>
                <counts group_id="E3" events="49" subjects_affected="41" subjects_at_risk="573"/>
                <counts group_id="E4" events="25" subjects_affected="18" subjects_at_risk="283"/>
                <counts group_id="E5" events="42" subjects_affected="30" subjects_at_risk="697"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication of study results are only allowed with prior written consent from Arena Pharmaceuticals, Inc.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Associate Director, Clinical Operations</name_or_title>
      <organization>Arena Pharmaceuticals, Inc.</organization>
      <phone>858-453-7200 ext 1602</phone>
      <email>sstubbe@arenapharm.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

